» Articles » PMID: 35079942

Left Atrial Structure and Function in Heart Failure with Reduced (HFrEF) Versus Preserved Ejection Fraction (HFpEF): Systematic Review and Meta-analysis

Overview
Journal Heart Fail Rev
Date 2022 Jan 26
PMID 35079942
Authors
Affiliations
Soon will be listed here.
Abstract

Left atrial (LA) structure and function in heart failure with reduced (HFrEF) versus preserved ejection fraction (HFpEF) is only established in small studies. Therefore, we conducted a systematic review of LA structure and function in order to find differences between patients with HFrEF and HFpEF. English literature on LA structure and function using echocardiography was reviewed to calculate pooled prevalence and weighted mean differences (WMD). A total of 61 studies, comprising 8806 patients with HFrEF and 9928 patients with HFpEF, were included. The pooled prevalence of atrial fibrillation (AF) was 34.4% versus 42.8% in the acute inpatient setting, and 20.1% versus 33.1% in the chronic outpatient setting when comparing between HFrEF and HFpEF. LA volume index (LAVi), LA reservoir global longitudinal strain (LAGLS), and E/e' was 59.7 versus 52.7 ml/m, 9.0% versus 18.9%, and 18.5 versus 14.0 in the acute inpatient setting, and 48.3 versus 38.2 ml/m, 12.8% versus 23.4%, and 16.9 versus 13.5 in the chronic outpatient setting when comparing HFrEF versus HFpEF, respectively. The relationship between LAVi and LAGLS was significant in HFpEF, but not in HFrEF. Also, in those studies that directly compared patients with HFrEF versus HFpEF, those with HFrEF had worse LAGLS [WMD = 16.3% (22.05,8.61); p < 0.001], and higher E/e' [WMD = -0.40 (-0.56, -0.24); p < 0.05], while LAVi was comparable. When focusing on acute hospitalized patients, E/e' was comparable between patients with HFrEF and HFpEF. Despite the higher burden of AF in HFpEF, patients with HFrEF had worse LA global function. Left atrial myopathy is not specifically related to HFpEF.

Citing Articles

Left Atrial Strain in Patients with Chronic Heart Failure with Preserved Ejection Fraction: A Narrative Review.

Man D, Motofelea A, Buda V, Velimirovici D, Bodea O, Duda-Seiman D Life (Basel). 2025; 15(2).

PMID: 40003722 PMC: 11857436. DOI: 10.3390/life15020313.


Patients with chronic heart failure and predominant left atrial versus left ventricular myopathy.

Jin X, Tay W, Soon D, Sim D, Loh S, Lee S Cardiovasc Ultrasound. 2025; 23(1):1.

PMID: 39894799 PMC: 11789358. DOI: 10.1186/s12947-024-00336-w.


Associations of Depression, Antidepressants with Atrial Fibrillation Risk in HFpEF Patients.

Fu Y, Feng S, Gu Z, Liu X, Zhu W, Wei B Rev Cardiovasc Med. 2024; 25(10):370.

PMID: 39484118 PMC: 11522750. DOI: 10.31083/j.rcm2510370.


Influencing factors and predictive model for left atrial appendage emptying velocity in nonvalvular AF patients.

He W, Yin L, Liu Q, Zhang Y, Zhao Y, Wang L Front Cardiovasc Med. 2024; 11:1468379.

PMID: 39364064 PMC: 11446783. DOI: 10.3389/fcvm.2024.1468379.


Potential Mechanisms of Epicardial Adipose Tissue Influencing Heart Failure with Preserved Ejection Fraction.

Li Q, Muhib U, Ma X, Liu Z, Gao F, Wang Z Rev Cardiovasc Med. 2024; 25(9):311.

PMID: 39355598 PMC: 11440401. DOI: 10.31083/j.rcm2509311.


References
1.
Saha S, Luo X, Gopal A, Govind S, Fang F, Liu M . Incremental prognostic value of multichamber deformation imaging and renal function status to predict adverse outcome in heart failure with reduced ejection fraction. Echocardiography. 2018; 35(4):450-458. DOI: 10.1111/echo.13821. View

2.
Khan M, Memon M, Murad M, Vaduganathan M, Greene S, Hall M . Left atrial function in heart failure with preserved ejection fraction: a systematic review and meta-analysis. Eur J Heart Fail. 2020; 22(3):472-485. DOI: 10.1002/ejhf.1643. View

3.
Donal E, Raud-Raynier P, de Place C, Gervais R, Rosier A, Roulaud M . Resting echocardiographic assessments of left atrial function and filling pressure interest in the understanding of exercise capacity in patients with chronic congestive heart failure. J Am Soc Echocardiogr. 2008; 21(6):703-10. DOI: 10.1016/j.echo.2007.10.002. View

4.
Sobirin M, Herry Y, Sofia S, Uddin I, Rifqi S, Tsutsui H . Effects of coenzyme Q10 supplementation on diastolic function in patients with heart failure with preserved ejection fraction. Drug Discov Ther. 2019; 13(1):38-46. DOI: 10.5582/ddt.2019.01004. View

5.
Kaye D, Petrie M, McKenzie S, HasenfuB G, Malek F, Post M . Impact of an interatrial shunt device on survival and heart failure hospitalization in patients with preserved ejection fraction. ESC Heart Fail. 2018; 6(1):62-69. PMC: 6351895. DOI: 10.1002/ehf2.12350. View